Wavemaker Three-Sixty Health (Wavemaker 360), a venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, has closed its Fund II at $64 million, surpassing its first fund nearly four times over.
Fund II’s Limited Partners (LPs) include hundreds of healthcare organisations and prominent healthcare executives across the United States, as well as some international investors.
The goal for Fund II is to invest into 40-50 early-stage companies (US and to a lesser extent international), with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health, medical device, telehealth, artificial intelligence, pharma-tech, science and marketplaces.
